Insider Transactions in Q1 2025 at Elevation Oncology, Inc. (ELEV)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2025
|
Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,189
-29.65%
|
$0
$0.67 P/Share
|
|
Feb 15
2025
|
Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+50.0%
|
-
|
|
Feb 15
2025
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,869
-13.42%
|
$0
$0.67 P/Share
|
|
Feb 15
2025
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,675
+24.99%
|
-
|
|
Feb 15
2025
|
David Dornan CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,152
-44.29%
|
$0
$0.67 P/Share
|
|
Feb 15
2025
|
David Dornan CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+50.0%
|
-
|
|
Feb 15
2025
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,211
-6.85%
|
$0
$0.67 P/Share
|
|
Feb 15
2025
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+15.68%
|
-
|